The global artificial kidney market size was estimated to be USD 1.84 billion in 2023 and is expected to reach at USD 6.63 billion by 2034 with a CAGR of 12.36% during the forecast period 2024-2034. Increasing prevalence of kidney-related diseases, a scarcity of kidney donors, surge in research & development activities to improve process of dialysis, rising investment by major market players, growing technological developments, increasing focus on the development of innovative & cost-effective products, and surge in regulatory approvals of advanced dialysis systems are some of the key factors boosting the market growth.
Surge in regulatory approvals of advanced dialysis systems is predicted to boost the market growth during the forecast period. An artificial kidney is a medical device that enables dialysis to be conducted at any time. Continuous research and development efforts are aimed at enhancing the dialysis process. In the late stages of kidney disease, the natural kidney loses its ability to filter and eliminate waste and excess fluids from the blood, necessitating dialysis treatment. Artificial kidneys aid the body in maintaining a healthy and safe life by performing these vital functions, reducing the need for frequent hospital visits for dialysis. For instance, in August 2023, Quanta Dialysis Technologies has obtained FDA 510(k) clearance for an extended version of the Quanta Dialysis System hemodialysis device, as stated in a press release.
By type, wearable artificial kidney was the highest revenue-grossing segment in the global artificial kidney market in 2023 owing to the increasing prevalence of renal and kidney disorders has resulted in a significant surge in the number of patients afflicted by these conditions, and rising funding by leading market players. For instance, in February 2023, NextKidney, a medical equipment company that developed the first portable hemodialysis machine, has successfully raised GBP 11.9 million (USD 14.82 million) in a Series B funding round. The company plans to allocate these funds for clinical trials and obtaining market clearance for its portable artificial kidney device. Additionally, implantable artificial kidney is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development activities and increasing number of clinical trial procedures.
By dialysis, hemodialysis was the highest revenue-grossing segment in the global artificial kidney market in 2023 owing to the surge in number of hemodialysis procedures being performed and growing regulatory approvals. Additionally, peritoneal dialysis is predicted to grow at fastest CAGR during the forecast period as it does not necessitate frequent trips to a dialysis center and can be conducted in the comfort of one's home. For instance, in November 2022, Baxter International Inc. has taken strides in scientific exchange by presenting 14 new data findings highlighting the importance of innovation in enhancing access to and the quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022. Baxter's Sharesource Remote Patient Management (RPM) digital health platform enables healthcare professionals to remotely monitor their patients' home dialysis treatments and make necessary therapy adjustments without requiring patients to make unplanned visits to the clinic.
By end-user, hospitals was the highest revenue-grossing segment in the global artificial kidney market in 2023 owing to the rising number of patients suffering from kidney disorders and growing clinical trial procedures. For instance, in June 2023, AWAK Technologies (AWAK) and Singapore General Hospital (SGH) have initiated a pre-pivotal clinical trial with the enrollment of their first participant. The objective of the trial is to evaluate the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Additionally, specialty clinics is predicted to grow at fastest CAGR during the forecast period owing to the surge in demand for peritoneal dialysis services, often offered by specialized clinics and increasing adoption of technologically advanced systems.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising prevalence of kidney disorders, growing research & development efforts, and increasing government initiatives. For instance, in August 2022, The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have announced a new prize competition through the Kidney Innovation Accelerator (KidneyX). This competition aims to advance the development of a fully functional bioartificial kidney. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in healthcare expenditure, increasing technological advancements, and growing focus on the development of novel systems. For instance, in May 2023, Medical device manufacturer Poly Medicure is considering the introduction of a locally produced and indigenous dialysis machine.
Surge in regulatory approvals of advanced dialysis systems is predicted to boost the market growth during the forecast period. An artificial kidney is a medical device that enables dialysis to be conducted at any time. Continuous research and development efforts are aimed at enhancing the dialysis process. In the late stages of kidney disease, the natural kidney loses its ability to filter and eliminate waste and excess fluids from the blood, necessitating dialysis treatment. Artificial kidneys aid the body in maintaining a healthy and safe life by performing these vital functions, reducing the need for frequent hospital visits for dialysis. For instance, in August 2023, Quanta Dialysis Technologies has obtained FDA 510(k) clearance for an extended version of the Quanta Dialysis System hemodialysis device, as stated in a press release.
By type, wearable artificial kidney was the highest revenue-grossing segment in the global artificial kidney market in 2023 owing to the increasing prevalence of renal and kidney disorders has resulted in a significant surge in the number of patients afflicted by these conditions, and rising funding by leading market players. For instance, in February 2023, NextKidney, a medical equipment company that developed the first portable hemodialysis machine, has successfully raised GBP 11.9 million (USD 14.82 million) in a Series B funding round. The company plans to allocate these funds for clinical trials and obtaining market clearance for its portable artificial kidney device. Additionally, implantable artificial kidney is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development activities and increasing number of clinical trial procedures.
By dialysis, hemodialysis was the highest revenue-grossing segment in the global artificial kidney market in 2023 owing to the surge in number of hemodialysis procedures being performed and growing regulatory approvals. Additionally, peritoneal dialysis is predicted to grow at fastest CAGR during the forecast period as it does not necessitate frequent trips to a dialysis center and can be conducted in the comfort of one's home. For instance, in November 2022, Baxter International Inc. has taken strides in scientific exchange by presenting 14 new data findings highlighting the importance of innovation in enhancing access to and the quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022. Baxter's Sharesource Remote Patient Management (RPM) digital health platform enables healthcare professionals to remotely monitor their patients' home dialysis treatments and make necessary therapy adjustments without requiring patients to make unplanned visits to the clinic.
By end-user, hospitals was the highest revenue-grossing segment in the global artificial kidney market in 2023 owing to the rising number of patients suffering from kidney disorders and growing clinical trial procedures. For instance, in June 2023, AWAK Technologies (AWAK) and Singapore General Hospital (SGH) have initiated a pre-pivotal clinical trial with the enrollment of their first participant. The objective of the trial is to evaluate the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Additionally, specialty clinics is predicted to grow at fastest CAGR during the forecast period owing to the surge in demand for peritoneal dialysis services, often offered by specialized clinics and increasing adoption of technologically advanced systems.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising prevalence of kidney disorders, growing research & development efforts, and increasing government initiatives. For instance, in August 2022, The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have announced a new prize competition through the Kidney Innovation Accelerator (KidneyX). This competition aims to advance the development of a fully functional bioartificial kidney. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in healthcare expenditure, increasing technological advancements, and growing focus on the development of novel systems. For instance, in May 2023, Medical device manufacturer Poly Medicure is considering the introduction of a locally produced and indigenous dialysis machine.
Segmentation: Artificial Kidney Market Report 2023 - 2034
Artificial Kidney Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Implantable Artificial Kidneys
- Wearable Artificial Kidney
Artificial Kidney Market Analysis & Forecast by Dialysis 2023 - 2034 (Revenue USD Bn)
- Peritoneal Dialysis
- Hemodialysis Dialysis
Artificial Kidney Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
Artificial Kidney Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Artificial Kidney Market: Type Estimates & Trend Analysis
8. Artificial Kidney Market: Dialysis Estimates & Trend Analysis
9. Artificial Kidney Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Artificial Kidney Market
12. Europe Global Artificial Kidney Market
13. Asia Pacific Global Artificial Kidney Market
14. Latin America Global Artificial Kidney Market
15. MEA Global Artificial Kidney Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Nikkiso Co. Ltd
- Asahi Kasei Medical Co. Ltd.
- Nanodialysis
- Medtronic
- B. Braun Melsungen AG
- AWAK Technologies
- Baxter
- DaVita Inc
- KAWASUMI LABORATORIES
- NIPRO Medical Corporation
- Fresenius Medical Care AG & Co. KGaA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 1.84 Billion |
| Forecasted Market Value ( USD | $ 6.63 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
